A carregar...
Duvelisib: A Phosphoinositide-3 Kinase δ/γ Inhibitor for Chronic Lymphocytic Leukemia
INTRODUCTION: Frontline chemotherapy is successful against chronic lymphocytic leukemia (CLL), but results in untoward toxicity. Further, prognostic factors, cytogenetic anomalies, and compensatory cellular signaling lead to therapy resistance or disease relapse. Therefore, for the past few years, d...
Na minha lista:
| Publicado no: | Expert Opin Investig Drugs |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5584596/ https://ncbi.nlm.nih.gov/pubmed/28388280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2017.1312338 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|